Oncogenic BRAF induces whole-genome doubling through suppression of cytokinesis
Open Access
- 15 July 2022
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-17
Abstract
Melanomas and other solid tumors commonly have increased ploidy, with near-tetraploid karyotypes being most frequently observed. Such karyotypes have been shown to arise through whole-genome doubling events that occur during early stages of tumor progression. The generation of tetraploid cells via whole-genome doubling is proposed to allow nascent tumor cells the ability to sample various pro-tumorigenic genomic configurations while avoiding the negative consequences that chromosomal gains or losses have in diploid cells. Whereas a high prevalence of whole-genome doubling events has been established, the means by which whole-genome doubling arises is unclear. Here, we find that BRAFV600E, the most common mutation in melanomas, can induce whole-genome doubling via cytokinesis failure in vitro and in a zebrafish melanoma model. Mechanistically, BRAFV600E causes decreased activation and localization of RhoA, a critical cytokinesis regulator. BRAFV600E activity during G1/S phases of the cell cycle is required to suppress cytokinesis. During G1/S, BRAFV600E activity causes inappropriate centriole amplification, which is linked in part to inhibition of RhoA and suppression of cytokinesis. Together these data suggest that common abnormalities of melanomas linked to tumorigenesis – amplified centrosomes and whole-genome doubling events – can be induced by oncogenic BRAF and other mutations that increase RAS/MAPK pathway activity.Keywords
All Related Versions
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR063850)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (1F30CA228388)
- U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (5T32GM008541, GM117150)
- U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
- Harry J. Lloyd Charitable Trust
- Melanoma Research Alliance (Jackie King Young Award)
This publication has 106 references indexed in Scilit:
- Pan-cancer patterns of somatic copy number alterationNature Genetics, 2013
- Dissecting the genomic complexity underlying medulloblastomaNature, 2012
- Chromosomal instability and aneuploidy in cancer: from yeast to manEMBO Reports, 2012
- A MEK-independent role for CRAF in mitosis and tumor progressionNature Medicine, 2011
- The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onsetNature, 2011
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAFNature, 2010
- Human papillomavirus 16 E5 induces bi-nucleated cell formation by cell–cell fusionVirology, 2009
- Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle ProgressionCell, 2008
- Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replicationNature, 2006
- The MAP kinase pathway is required for entry into mitosis and cell survivalOncogene, 2004